2010 Fiscal Year Final Research Report
Development of discovering technology to quantify the biomarker for minimally invasive diagnostics.
Project/Area Number |
21790173
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Medical pharmacy
|
Research Institution | National Institute of Biomedical Innovation |
Principal Investigator |
鎌田 春彦 National Institute of Biomedical Innovation, 創薬基盤研究部, サブプロジェクトリーダー (00324509)
|
Project Period (FY) |
2009 – 2010
|
Keywords | バイオマーカー / プロテオーム解析 / 膜蛋白質 / ビオチンラベル化 / 肝炎 |
Research Abstract |
The proteins they express at the time of disease and which are related to organ dysfunction are poorly characterized. Our group has developed a general chemical proteomics approach for the identification of biomarker proteins. The aim of this study was to identify protein biomarkers present in sinusoidal endothelial cells following hepatic injury using chemical proteomics employing in vivo biotinylation. We performed a proteomic study in a mouse model of massive hepatocyte apoptosis in tumor necrosis factor (TNF)/D-(+)-galactosamine (GalN) animals induced by the combined administration of GalN and TNF. In vivo biotinylation was carried out by perfusing mice with a reactive ester derivative of biotin that enables the covalent modification of proteins. Protein expression was analyzed using purified proteins from hepatitic and normal livers. The biotinylated proteins were purified from liver extracts using streptavidin beads, digested on the resin by trypsin and subjected to mass spectrometry for identification. These results indicate that the sinusoidal endothelial biomarkers expressed on liver injury reflect the molecular pathobiology and the mechanisms of hepatitis induction.
|
-
[Journal Article] Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.2010
Author(s)
Nomura T., Abe Y., Kamada H., Inoue M., Kawara T., Arita S., Furuya T., Minowa K., Yoshioka Y., Shibata H., Kayamuro H., Yamashita T., Nagano K., Yoshikawa T., Mukai Y., Nakagawa S., Tsunoda S., Tsutsumi Y.
-
Journal Title
Pharmazie 65(2)
Pages: 93-96
-
[Journal Article] Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1- or TNFR2.2010
Author(s)
Shibata H., Abe Y., Yoshioka Y., Nomura T., Sato M., Kayamuro H., Kawara T., Arita S., Furuya T., Nagano K., Yoshikawa T., Kamada H., Tsunoda S., Tsutsumi Y.
-
Journal Title
Cytokine 50(1)
Pages: 75-83
-
-
[Journal Article] Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells.2010
Author(s)
Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Tsunoda S., Tsutsumi Y.
-
Journal Title
Pharmazie 65(3)
Pages: 199-201
-
[Journal Article] Mutant TNF-alpha, mTNF-K90R, is a novel mucosal vaccine adjuvant candidate against HIV.2010
Author(s)
Kayamuro H., Abe Y., Yoshioka Y., Katayama K., Yoshida T., Yamashita K., Yoshikawa T., Kawai Y., Mayumi T., Hiroi T., Itoh N., Nagano K., Kamada H., Tsunoda S., Tsutsumi Y.
-
Journal Title
Pharmazie 65(4)
Pages: 254-6
-
[Journal Article] Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape.2010
Author(s)
Yamashita K., Yoshioka Y., Higashisaka K., Morishita Y., Yoshida T., Fujimura M., Kayamuro H., Nabeshi H., Yamashita T., Nagano K., Abe Y., Kamada H., Kawai Y., Mayumi T., Yoshikawa T., Itoh N., Tsunoda S., Tsutsumi Y.
-
Journal Title
Inflammation 33(4)
Pages: 276-80
-
[Journal Article] Urban aerosol induce pro-inflammatory cytokine production in macrophages and cause airway inflammation in vivo.2010
Author(s)
Yoshida T., Yoshioka Y., Fujimura M., Kayamuro H., Yamashita K., Higashisaka K., Nakanishi R., Morishita Y., Nabeshi H., Yamashita T., Muroi M., Tanamoto K., Nagano K., Abe Y., Kamada H., Kawai Y., Mayumi T., Itoh N., Yoshikawa T., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biol.Pharm.Bull. 33(5)
Pages: 780-3
-
[Journal Article] Arsenic trioxide alters expression and oxidative modification of the proteome in leukemic cells.2010
Author(s)
Nabeshi H., Yoshikawa T., Kamada H., Shibata H., Sugita T., Abe Y., Nagano K., Nomura T., Minowa K., Tsunoda S., Tsutsumi Y.
-
Journal Title
Pharmazie 65
Pages: 702-707
-
[Journal Article] The IL-1 family cytokines as mucosal vaccine adjuvant for the induction of protective immunity against influenza virus.2010
Author(s)
Kayamuro H., Yoshioka Y., Abe Y., Arita S., Katayama K., Nomura T., Yoshikawa T., Kubota-Koketsu R., Ikuta K., Okamoto S., Mori Y., Kunisawa J., Kiyono H., Itoh N., Nagano K., Kamada H., Tsutsumi Y., Tsunoda S.
-
Journal Title
J.Virol. 84(24)
Pages: 12703-12712
-
[Journal Article] Potential adjuvant effect of intranasal urban aerosols in mice through induction of dendritic cell maturation.2010
Author(s)
Yoshida T., Yoshioka Y., Fujimura M., Yamashita K., Higashisaka K., Nakanishi R., Morishita Y., Kayamuro H., Nabeshi H., Nagano K., Abe Y., Kamada H., Tsunoda S., Yoshikawa T., Itoh N., Tsutsumi Y.
-
Journal Title
Toxicol.Lett. 199(3)
Pages: 383-388
-
-
[Journal Article] Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.2009
Author(s)
Mukai Y., Shibata H., Nakamura T., Yoshioka Y., Abe Y., Nomura T., Taniai M., Ohta T., Ikemizu S., Nakagawa S., Tsunoda S., Kamada H., Yamagata Y., Tsutsumi Y.
-
Journal Title
J.Mol.Biol. 385
Pages: 1221-1229
-
-
-
-
[Journal Article] The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.2009
Author(s)
Yoshikawa T., Sugita T., Mukai Y., Yamanada N., Nagano K., Nabeshi H., Shibata H., Yoshioka Y., Nakagawa S., Kamada H., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biomaterials. 30(19)
Pages: 3318-23
-
[Journal Article] Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF : useful information for designing artificial proteo-antagonists.2009
Author(s)
Mukai Y., Nakamura T., Yoshioka Y., Shibata H., Abe Y., Nomura T., Taniai M., Ohta T., Nakagawa S., Tsunoda S., Kamada H., Yamagata Y., Tsutsumi Y.
-
Journal Title
J.Biochem. 146(2)
Pages: 167-72
-
[Journal Article] TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant.2009
Author(s)
Kayamuro H., Yoshioka Y., Abe Y., Katayama K., Yoshida T., Yamashita K., Yoshikawa T., Hiroi T., Itoh N., Kawai Y., Mayumi T., Kamada H., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biochem.Biophys.Res.Commun. 384(3)
Pages: 296-300
-
[Journal Article] Arsenic trioxide has the inhibitory effect on transmission of human T-cell leukemia virus type 1.2009
Author(s)
Nabeshi H., Yoshikawa T., Kamada H., Shibata H., Sugita T., Abe Y., Nagano K., Nomura T., Minowa K., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biol.Pharm.Bull. 32(7)
Pages: 1286-8
-
[Journal Article] The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.2009
Author(s)
Kayamuro H., Abe Y., Yoshioka Y., Katayama K., Yoshida T., Yamashita K., Yoshikawa T., Hiroi T., Itoh N., Kawai Y., Kamada H., Nagano K., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biomaterials 30(29)
Pages: 5869-5876
-
[Journal Article] Novel protein engineering strategy for creating highly receptor-selective mutant TNFs.2009
Author(s)
Nomura T., Abe Y., Kamada H., Inoue M., Kawara T., Arita S., Furuya T., Yoshioka Y., Shibata H., Kayamuro H., Yamashita T., Nagano K., Yoshikawa T., Mukai Y., Nakagawa S., Taniai M., Ohta T., Tsunoda S., Tsutsumi Y.
-
Journal Title
Biochem.Biophys.Res.Commun. 30;388(4)
Pages: 667-71
-
[Journal Article] The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF.2009
Author(s)
Shibata H., Yoshioka Y., Abe Y., Ohkawa A., Nomura T., Minowa K., Mukai Y., Nakagawa S., Taniai M., Ohta T., Tsunoda S., Kamada H., Tsutsumi Y.
-
Journal Title
Biomaterials. 30(34)
Pages: 6638-6647
-
-
-
-
-
-